Resources

Publications

11/21/2024
- Oncology
Molecular Landscape of Extra-Pulmonary Small Cell Neuroendocrine Carcinomas Based on Site of Origin
NANETS 2024
11/21/2024
- Oncology
Uncovering Genomic Differences Between Small and Large Cell Extra-Pulmonary Neuroendocrine Carcinomas
NANETS 2024
11/20/2024
- Oncology
HER2 Expression and Associated Real World Overall Survival (RWOS) in Patients With Select Solid Tumors
ISPOR Europe 2024
11/20/2024
- Oncology
Identifying Fit-for-Emulation Data: Adaptation of a Structured Data Feasibility Assessment Process for Real-World Oncology Trial Emulations
ISPOR Europe 2024
11/16/2024
- Oncology
Integrated Transcriptomic Analysis of CIC::DUX4 Fusion Sarcomas Reveals Elevated Proliferation Signaling and Implicates DNA Repair Gene Pole
CTOS 2024
11/14/2024
- Oncology
Digital Profiling of Gene Expression From Histology Images With Linearized Attention
Nature Communications
11/12/2024
- Oncology
PD-1 Blockade Plus Cisplatin-Based Chemotherapy in Patients With Small Cell/Neuroendocrine Bladder and Prostate Cancers
Cell Reports Medicine
11/08/2024
- Oncology
A Tumor-Naive ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis From the GALAXY Study in CIRCULATE-Japan
Clinical Cancer Research
11/05/2024
- Oncology
Development and Validation of the Immune Profile Score (IPS), a Novel Multi-Omic Algorithmic Assay for Stratifying Outcomes in a Real-World Cohort of Advanced Solid Cancer Patients Treated With Immune Checkpoint Inhibitors
MedRxiv
11/05/2024
- Oncology
A Comprehensive Whole Genome Sequencing Assay Provides Robust Characterization of Clinically Relevant Genomic Alterations across Myeloid Malignancies Concordant with Matched Results from Targeted DNA, Whole Transcriptome RNA and Cytogenetic Profiling
ASH 2024

19 20 21